This role provides scientific and strategic leadership overseeing Early Development asset-specific programs within the Multiple Sclerosis and Immunology Development Unit
Job Summary
This role provides scientific and strategic leadership overseeing Early Development asset-specific programs within the Multiple Sclerosis and Immunology Development Unit.
The successful candidate will manage 2-5 programs focusing on First-in-Human, First-in-Patient, and Proof of Biology goals with potential for pivotal global regulatory filings.
Biogen offers a competitive compensation package including short-term and long-term incentives, comprehensive health benefits, and up to $10,000 in annual tuition reimbursement.
Matching Summary
This role provides scientific and strategic leadership overseeing Early Development asset-specific programs within the Multiple Sclerosis and Immunology Development Unit.
Salary
Base: $288,000.00-$407,000.00; Bonus/Equity: Short term and long-term incentives including cash bonus and equity; Benefits: Medical, Dental, Vision, Life, 401(k) match, Tuition reimbursement
Skills & Requirements
Must-have
MD with significant clinical experience
10 years clinical and research experience
5 years management experience in industry
Extensive immunology drug development experience
Strategic R2D transition leadership
Nice-to-have
Subspecialty training in Rheumatology or Dermatology
Visionary leadership style
Strong problem-solving skills
Collaborative team-building approach
Passion for scientific innovation
Key Requirements
MD degree required
Internal medicine clinical training highly desired